Managing Side Effects Based on Dosing Time Gastrointestinal side effects particularly nausea, vomiting, diarrhoea, and constipationare the most commonly reported adverse effects of GLP-1 medications, especially during the initial weeks of treatment or following dose escalation
While these medications can be transformative for weight loss and diabetes management, they sometimes come with side effects that arent always highlighted in standard medication guides
The most common adverse effects of tirzepatide are gastrointestinal, including nausea (occurring in 15-30% of patients), diarrhea, vomiting, constipation, and abdominal discomfort
The 12 mg arm was the first obesity pharmacotherapy readout to cross the 20% line
Testing can help you to understand your health baseline, and when on a semaglutide, it can help you to monitor potential side effects and measure how your weight loss is reducing your chronic disease risk over time
Inter-regulation of gastric emptying and incretin hormone secretion: implications for postprandial glycemic control